EG appoints joint managing directors in response to growth
Roger Parker and Chris Pak have been promoted as EG's new joint managing directors, taking over the roles of head of distribution and chief investment officer, respectively.
Stay updated with breaking news from Chris Pak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roger Parker and Chris Pak have been promoted as EG's new joint managing directors, taking over the roles of head of distribution and chief investment officer, respectively.
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Molecular Targeting Technologies Inc. (MTTI), a clinical stage biotech company focused on developing innovative
Molecular Targeting Technologies Inc. (MTTI), a clinical stage biotech company focused on developing innovative therapies for rare cancers, and ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical
EG's Australian Core Enhanced portfolio (ACE) has surpassed $1 billion after the recent acquisition of a 50% stake in Grand Plaza Shopping Centre, Browns Plains, Queensland.
WEST CHESTER, Pa.--(BUSINESS WIRE)--Jan 26, 2022--